1. Home
  2. SNX vs HOLX Comparison

SNX vs HOLX Comparison

Compare SNX & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TD SYNNEX Corporation

SNX

TD SYNNEX Corporation

HOLD

Current Price

$225.78

Market Cap

17.2B

Sector

Technology

ML Signal

HOLD

Logo Hologic Inc.

HOLX

Hologic Inc.

HOLD

Current Price

$76.02

Market Cap

16.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNX
HOLX
Founded
1980
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Medical Electronics
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.2B
16.9B
IPO Year
2003
1995

Fundamental Metrics

Financial Performance
Metric
SNX
HOLX
Price
$225.78
$76.02
Analyst Decision
Strong Buy
Hold
Analyst Count
10
13
Target Price
$198.70
$77.89
AVG Volume (30 Days)
1.0M
20.9M
Earning Date
03-31-2026
04-30-2026
Dividend Yield
0.84%
N/A
EPS Growth
25.16
N/A
EPS
4.04
0.79
Revenue
$20,053,764,000.00
$4,100,500,000.00
Revenue This Year
$9.11
$4.74
Revenue Next Year
$5.69
$5.03
P/E Ratio
$56.02
$96.23
Revenue Growth
17.65
1.74
52 Week Low
$108.19
$51.90
52 Week High
$227.61
$76.07

Technical Indicators

Market Signals
Indicator
SNX
HOLX
Relative Strength Index (RSI) 82.66 69.09
Support Level $146.57 $75.10
Resistance Level N/A N/A
Average True Range (ATR) 5.73 0.19
MACD 1.36 0.03
Stochastic Oscillator 89.37 95.19

Price Performance

Historical Comparison
SNX
HOLX

About SNX TD SYNNEX Corporation

TD Synnex Corp is a distributor and solutions aggregator for the IT ecosystem. The company aggregates and distributes IT hardware, software, and systems including personal computing devices and peripherals, mobile phones and accessories, printers, server and data center infrastructure, hybrid cloud, security, networking, communications and storage solutions, and system components. Its geographical segments include the Americas, Europe, and APJ.

About HOLX Hologic Inc.

Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.

Share on Social Networks: